chr15-65077630-T-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_001101362.3(KBTBD13):c.815T>A(p.Ile272Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000905 in 1,590,312 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001101362.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000513 AC: 78AN: 151996Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000117 AC: 24AN: 205834Hom.: 0 AF XY: 0.0000608 AC XY: 7AN XY: 115106
GnomAD4 exome AF: 0.0000452 AC: 65AN: 1438198Hom.: 1 Cov.: 83 AF XY: 0.0000350 AC XY: 25AN XY: 715118
GnomAD4 genome AF: 0.000519 AC: 79AN: 152114Hom.: 0 Cov.: 34 AF XY: 0.000484 AC XY: 36AN XY: 74384
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.815T>A (p.I272N) alteration is located in exon 1 (coding exon 1) of the KBTBD13 gene. This alteration results from a T to A substitution at nucleotide position 815, causing the isoleucine (I) at amino acid position 272 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
KBTBD13-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Nemaline myopathy 6 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at